Return to Home Incidence > Table > Interpret

Interpretation of Incidence Rates Data

Incidence Rate Report for Virginia by County

Non-Hodgkin Lymphoma (All Stages^), 2014-2018

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Count

Explanation of Column Headers

Objective - The objective of *** is from the Healthy People 2020 project done by the Centers for Disease Control and Prevention.

Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Recent Trends - This is an interpretation of the AAPC/APC:

AAPC/APC (95% Confidence Interval) - the change in rate over time


Other Notes


Line by Line Interpretation of the Report


Virginia6


US (SEER+NPCR)1


Fairfax County6


Virginia Beach City6


Chesterfield County6


Henrico County6


Prince William County6


Loudoun County6


Chesapeake City6


Norfolk City6


Arlington County6


Roanoke County6


Richmond City6


Newport News City6


Albemarle County6


Hampton City6


Spotsylvania County6


Augusta County6


Bedford City and County6


Roanoke City6


Hanover County6


Stafford County6


James City County6


Rockingham County6


Alexandria City6


Lynchburg City6


Portsmouth City6


Franklin County6


Fauquier County6


Henry County6


Washington County6


Montgomery County6


Suffolk City6


Frederick County6


Campbell County6


Culpeper County6


Pittsylvania County6


Staunton City6


York County6


Gloucester County6


Shenandoah County6


Charlottesville City6


Harrisonburg City6


Danville City6


Orange County6


Waynesboro City6


Wythe County6


Isle of Wight County6


Accomack County6


Amherst County6


Prince George County6


Rockbridge County6


Carroll County6


Halifax County with South Boston City6


Page County6


Tazewell County6


Louisa County6


Mecklenburg County6


Manassas City6


Pulaski County6


Warren County6


Botetourt County6


Fluvanna County6


Caroline County6


Colonial Heights City6


Nelson County6


Petersburg City6


Powhatan County6


Wise County6


Dinwiddie County6


Goochland County6


Salem City6


Westmoreland County6


Buchanan County6


King George County6


New Kent County6


Winchester City6


Greene County6


Russell County6


Patrick County6


Southampton County6


Hopewell City6


Fredericksburg City6


Brunswick County6


Charlotte County6


Middlesex County6


Northampton County6


Alleghany County and Clifton Forge City6


Fairfax City6


Floyd County6


Scott County6


Smyth County6


Appomattox County6


Buckingham County6


Dickenson County6


Essex County6


Giles County6


Northumberland County6


Nottoway County6


Prince Edward County6


Williamsburg City6


Clarke County6


King William County6


Lee County6


Manassas Park City6


Amelia County6 Bath County6 Bland County6 Bristol City6 Buena Vista City6 Charles City County6 Covington City6 Craig County6 Cumberland County6 Emporia City6 Falls Church City6 Franklin City6 Galax City6 Grayson County6 Greensville County6 Highland County6 King and Queen County6 Lancaster County6 Lexington City6 Lunenburg County6 Madison County6 Martinsville City6 Mathews County6 Norton City6 Poquoson City6 Radford City6 Rappahannock County6 Richmond County6 Surry County6 Sussex County6

Notes:
Created by statecancerprofiles.cancer.gov on 05/23/2022 4:09 pm.

State Cancer Registries may provide more current or more local data.
Trend
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.

⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The 1969-2018 US Population Data File is used for SEER and NPCR incidence rates.
‡ Incidence data come from different sources. Due to different years of data availability, most of the trends are AAPCs based on APCs but some are APCs calculated in SEER*Stat. Please refer to the source for each area for additional information.

Rates and trends are computed using different standards for malignancy. For more information see malignant.html.

^ All Stages refers to any stage in the Surveillance, Epidemiology, and End Results (SEER) summary stage.
*** No Healthy People 2020 Objective for this cancer.
Healthy People 2020 Objectives provided by the Centers for Disease Control and Prevention.

* Data has been suppressed to ensure confidentiality and stability of rate estimates. Counts are suppressed if fewer than 16 records were reported in a specific area-sex-race category. If an average count of 3 is shown, the total number of cases for the time period is 16 or more which exceeds suppression threshold (but is rounded to 3).

1 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database (2001-2018) - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2020 submission.
6 Source: National Program of Cancer Registries SEER*Stat Database (2001-2018) - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2020 submission).
8 Source: Incidence data provided by the SEER Program. AAPCs are calculated by the Joinpoint Regression Program and are based on APCs. Data are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84,85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Population counts for denominators are based on Census populations as modifed by NCI. The 1969-2018 US Population Data File is used with SEER November 2020 data.

Interpret Rankings provides insight into interpreting cancer incidence statistics. When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate.

Data for United States does not include Puerto Rico.

When displaying county information, the CI*Rank for the state is not shown because it's not comparable. To see the state CI*Rank please view the statistics at the US By State level.